Phenazepam's safety pharmacogenetic study results: influence of CYP2C9, CYP3A5, CYP2C19, ABCB1 and CYP3A4/5 isoenzymes' activity

被引：0
|
作者：
Ivashchenko, D. [1 ]
Ryzhikova, K. [2 ]
Sozaeva, Z. [2 ]
Grishina, E. [2 ]
Zastrozhin, M. [3 ]
Bryun, E. [3 ]
Sychev, D. [4 ]
机构：
[1] Russian Med Acad Continuous Profess Educ, Dept Appl Problems Personalized Med, Moscow, Russia
[2] Russian Med Acad Continuous Profess Educ, Dept Mol Biol Studies, Moscow, Russia
[3] Russian Med Acad Continuous Profess Educ, Dept Narcol, Moscow, Russia
[4] Russian Med Acad Continuous Profess Educ, Dept Clin Pharmacol, Moscow, Russia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2018年 / 28卷
关键词：
D O I：
10.1016/j.euroneuro.2017.12.037
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.1.019
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [31] Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
    Belmonte, Carmen
    Ochoa, Dolores
    Roman, Manuel
    Saiz-Rodriguez, Miriam
    Wojnicz, Aneta
    Isabel Gomez-Sanchez, Clara
    Martin-Vilchez, Samuel
    Abad-Santos, Francisco
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) : 596 - 605
  • [32] GENETIC VARIATION AND PREDICTED PHENOTYPES IN CYP2C9, CYP2C19, CYP3A4, CYP3A5 AND CYP2D6 GENES AMONG 552 PATIENTS WITH UNCONTROLLED TREATED HYPERTENSION
    Rognstad, Stine
    Halvorsen, Lene Vernas
    Soraas, Camilla Lund
    Aune, Arleen
    Brobak, Karl Marius
    Olsen, Eirik
    Bergland, Ola Undrum
    Kjaer, Vibeke Nordheim
    Hjornholm, Ulla
    Tuv, Silja Skogstad
    Nordal, Kristin Reiersen
    Svarstad, Anja Camilla
    Gerdts, Eva
    Mo, Rune
    Hoieggen, Aud
    Kjeldsen, Sverre Erik
    Rostrup, Morten
    Larstorp, Anne Cecilie K.
    Opdal, Mimi Stokke
    JOURNAL OF HYPERTENSION, 2023, 41 : E315 - E315
  • [33] Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors
    Wadelius, M
    Sörlin, K
    Wallerman, O
    Karlsson, J
    Yue, QY
    Magnusson, PKE
    Wadelius, C
    Melhus, H
    PHARMACOGENOMICS JOURNAL, 2004, 4 (01): : 40 - 48
  • [34] 泸州地区苗族人群CYP2C19、ABCB1、CYP3A4和CYP3A5基因多态性分析
    胡功利
    王国俊
    杨婷
    陈竹
    叶云
    中国药房, 2016, 27 (32) : 4473 - 4476
  • [35] Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors
    M Wadelius
    K Sörlin
    O Wallerman
    J Karlsson
    Q-Y Yue
    P K E Magnusson
    C Wadelius
    H Melhus
    The Pharmacogenomics Journal, 2004, 4 : 40 - 48
  • [36] GENETIC POLYMORPHISMS OF CYTOCHROME P450 (CYP) 2C9, CYP2C19, CYP2D6, CYP3A4, AND CYP3A5 IN A KORSIAN POPULATION
    Lim, Y.
    Kim, E.
    Lee, Y.
    Cha, E.
    Jung, H.
    Kim, J.
    Lee, S.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S61 - S61
  • [37] SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS
    De Andres, F.
    Paulmichl, M.
    Llerena, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S61 - S61
  • [38] Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant Recipients
    Wang, Zijie
    Zheng, Ming
    Yang, Haiwei
    Han, Zhijian
    Tao, Jun
    Chen, Hao
    Sun, Li
    Guo, Miao
    Wang, Libin
    Tan, Ruoyun
    Wei, Ji-Fu
    Gu, Min
    CURRENT DRUG METABOLISM, 2019, 20 (07) : 609 - 618
  • [39] CYP3A4, CYP3A5 and CYP2C9 are responsible for the N-demethylation of meperidtne to normeperidine in vitro.
    Santucci, R
    Innocenti, F
    Ramirez, J
    House, L
    Ratain, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P79 - P79
  • [40] Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray
    Dong, Yuanyuan
    Xiao, Huasheng
    Wang, Qi
    Zhang, Chunxiu
    Liu, Xiuming
    Yao, Na
    Sheng, Haihui
    Li, Haiyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18917 - 18926
12345